Demahy v. Actavis, Inc., No. 08-31204
In an action based on injuries plaintiff allegedly sustained by taking defendant's drug, a denial of defendant's motion to dismiss is affirmed where the federal regulatory regime governing pharmaceuticals did not preempt state-law failure-to-warn claims against manufacturers of generic drugs.
Filed January 8, 2010
Opinion by Judge Higginbotham